News & Events
The European Commission has approved the first disease-modifying therapy, ocrelizumab, for early primary progressive MS (PPMS).
Helmut Butzkueven, who led the development of MSBase with support from MS Research Australia, has received the…
Third annual meeting (Encuentro) brings together MS organisations from 16 Latin American countries to share learnings and…
More than 900 health professionals and representatives from 38 countries gathered in Dubai for MENACTRIMS 2017, which…
This year marked the 50th anniversary of the MS International Federation, giving us a valuable opportunity to…
Canadian research reveals the positive effects of taking MS medications as prescribed on a person's general health
Cold water in the mouth can help reduce heat sensitivity, a common symptom of MS.
Chronic Cerebrospinal Venous Insufficiency (CCSVI) describes a potential reduction in blood flow in the major veins that…
Study reveals important mechanism that allows immune cells to attack myelin in MS
A major investigation into the critical role of MS Specialist Nurses in Australia could support MS Australia’s…
Students and staff from "Universidade Futura do Pintor" renovated the facilities as part of a partnership between…
Belgium’s Deputy Prime Minister, Kris Peeters, presented eight companies with awards to recognise their commitment to hiring…